ATE392619T1 - Verfahren zur diagnose von synovialen oder osteoartikulären erkrankungen - Google Patents

Verfahren zur diagnose von synovialen oder osteoartikulären erkrankungen

Info

Publication number
ATE392619T1
ATE392619T1 AT00948068T AT00948068T ATE392619T1 AT E392619 T1 ATE392619 T1 AT E392619T1 AT 00948068 T AT00948068 T AT 00948068T AT 00948068 T AT00948068 T AT 00948068T AT E392619 T1 ATE392619 T1 AT E392619T1
Authority
AT
Austria
Prior art keywords
synovial
diagnosing
osteoarticular diseases
osteoarticular
diseases
Prior art date
Application number
AT00948068T
Other languages
English (en)
Inventor
Pierre Delmas
Patrick Garnero
Evelyne Gineyts
Original Assignee
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of ATE392619T1 publication Critical patent/ATE392619T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT00948068T 1999-07-01 2000-06-30 Verfahren zur diagnose von synovialen oder osteoartikulären erkrankungen ATE392619T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9908502A FR2795823B1 (fr) 1999-07-01 1999-07-01 Methodes et kits pour le diagnostic ou le suivi d'une pathologie synoviale ou osteoarticulaire comprenant l'utilisation d'un marqueur specifique de la degradation du tissu synovial

Publications (1)

Publication Number Publication Date
ATE392619T1 true ATE392619T1 (de) 2008-05-15

Family

ID=9547607

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00948068T ATE392619T1 (de) 1999-07-01 2000-06-30 Verfahren zur diagnose von synovialen oder osteoartikulären erkrankungen

Country Status (9)

Country Link
US (1) US7015048B2 (de)
EP (1) EP1210604B1 (de)
JP (1) JP2003503737A (de)
AT (1) ATE392619T1 (de)
CA (1) CA2377886A1 (de)
DE (1) DE60038614T2 (de)
ES (1) ES2304351T3 (de)
FR (1) FR2795823B1 (de)
WO (1) WO2001002864A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002038794A2 (en) 2000-11-09 2002-05-16 The Brigham And Women's Hospital, Inc. Cardiovascular disease diagnostic and therapeutic targets
ES2375181T3 (es) 2002-05-09 2012-02-27 The Brigham And Women's Hospital, Inc. 1l 1rl-1 como un marcador de enfermedades cardiovasculares.
PL2386860T4 (pl) 2006-04-24 2015-09-30 Critical Care Diagnostics Inc Przewidywanie śmiertelności i wykrywanie poważnej choroby
DK2482078T3 (en) * 2006-05-01 2016-05-02 Critical Care Diagnostics Inc Cardiovascular disease diagnosis
SI2019965T1 (sl) * 2006-05-02 2015-10-30 Critical Care Diagnostics, Inc. Diferencialna diagnoza med pljučno boleznijo in boleznijo srca in ožilja
FR2908413B1 (fr) 2006-11-15 2009-03-06 Synarc Soc Par Actions Simplif Marqueur specifique d'une degradation oxydative de tissus contenant du collagene de type iii,moyens et methodes,kits de diagnostic de suivi ou de pronostic des pathologies ciblees par ce marqueur.
RU2344486C1 (ru) * 2007-09-10 2009-01-20 Федеральное государственное учреждение "Российский научный центр "Восстановительная травматология и ортопедия" имени академика Г.А. Илизарова Федерального агентства по высокотехнологичной медицинской помощи" Способ моделирования дистрофического поражения тазобедренного сустава
PT3093663T (pt) 2008-04-18 2018-10-19 Critical Care Diagnostics Inc Previsão do risco de eventos cardíacos adversos maiores
WO2009153783A1 (en) * 2008-06-16 2009-12-23 Mor Research Applications Ltd. Monitoring skin metabolism products for evaluating burn injury
IN2015DN01767A (de) 2012-08-21 2015-05-29 Critical Care Diagnostics Inc
JP7195568B2 (ja) * 2018-03-22 2022-12-26 学校法人上智学院 複合体

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444879A (en) * 1981-01-29 1984-04-24 Science Research Center, Inc. Immunoassay with article having support film and immunological counterpart of analyte
US4973666A (en) * 1987-11-06 1990-11-27 Washington Research Foundation Peptide fragments containing HP and LP cross-links
US5702909A (en) * 1987-11-06 1997-12-30 Washington Research Foundation Methods of detecting collagen type II degradation in vivo
GB8815174D0 (en) * 1988-06-25 1988-08-03 Rowett Research Inst Method of monitoring collagen degradation
US5283197A (en) * 1988-06-25 1994-02-01 The Rowett Research Institute Method of monitoring collagen degradation
US5314804A (en) * 1992-03-24 1994-05-24 Serim Research Corporation Test for Helicobacter pylori
US5736344A (en) * 1992-12-17 1998-04-07 Metra Biosystems, Inc. Serum pyridinium crosslinks assay
WO1995002188A1 (en) * 1993-07-12 1995-01-19 The Regents Of The University Of California Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices

Also Published As

Publication number Publication date
ES2304351T3 (es) 2008-10-16
FR2795823A1 (fr) 2001-01-05
CA2377886A1 (fr) 2001-01-11
EP1210604A1 (de) 2002-06-05
FR2795823B1 (fr) 2001-11-23
DE60038614D1 (de) 2008-05-29
US7015048B2 (en) 2006-03-21
US20020172978A1 (en) 2002-11-21
JP2003503737A (ja) 2003-01-28
EP1210604B1 (de) 2008-04-16
WO2001002864A1 (fr) 2001-01-11
DE60038614T2 (de) 2009-06-25

Similar Documents

Publication Publication Date Title
ATE400219T1 (de) Verfahren zur quantifizierung von menschlicher wachsamkeit
AU4694499A (en) Trace level detection of analytes using artificial olfactometry
AU2001247311A1 (en) A system and method for obtaining, processing and evaluating patient information for diagnosing disease and selecting treatment
EP1085418A3 (de) Verfahren und System zur Prüfung des Verhaltens von Prozeduren
ATE230487T1 (de) Verfahren zur frühen diagnose von carcinomen
DE69921463D1 (de) Verfahren um blutzellzählungen durchzuführen
DE60233485D1 (de) Verfahren zur diagnose, behandlung und prävention von knochenverlust
DE60325617D1 (de) Verfahren zur diagnose von bauchspeicheldrüsenkrebs
NO20000862L (no) Elektrokjemisk system for bestemmelse av blodkoaguleringstid
DE60037300D1 (de) Verfahren und Vorrichtung zur modellbasierten Diagnose
DE59908478D1 (de) Informations-, bedien- und/oder beobachtungssystem mit modellbasierter benutzeroberfläche und verfahren zum modellbasierten bedienen und/oder beobachten
DE60038614D1 (de) Verfahren zur diagnose von synovialen oder osteoartikulären erkrankungen
ATE111228T1 (de) Verfahren zur überwachung des kollagenabbaus.
DE69510336D1 (de) Verfahren zur diagnose von praeklampsie
DE69621499D1 (de) Kalkulator zur Abschätzung der Maximalwahrscheinlichkeits-Abfolge und Verfahren hierfür
DE69806913D1 (de) Verfahren und vorrichtung für ein flügelstabilisiertes geschoss, das eine bodensogreduzierung hat
DE60016242D1 (de) Verfahren zur diagnose oder prognose von altersbedingter maculadegeneration
DE60033339D1 (de) Verfahren zur Überwachung des Takts und Vorrichtung zur Datenübertragung, die das Verfahren verwendet
DE69934983D1 (de) Verfahren, vorrichtung und bildgebungsmodus für tomographische bildgebung
ATE422334T1 (de) System und verfahren zur gewebeanalyse
WO2001037779A3 (en) A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer
DE50007635D1 (de) Verfahren zur diagnose von sjögren-syndrom
ATE277352T1 (de) Einetenascin-c isoform als marker für neoplasmen
EP0774970A4 (de) Verfahren zur verwendung von hyaluronsäure zur detektion, lokalisation und diagnose von tumoren
WO2003069553A3 (en) Method of image analysis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties